A new study has evaluated the effectiveness of different treatment options for basal cell carcinoma. Learn more.

I recently heard about a type of skin cancer called Merkel cell carcinoma. I’m not familiar with this condition. Can you explain what it is? Do I need to do anything different to protect myself?

Question: I recently noticed a strange growth on my bottom eyelid. It isn’t coming out of a hair follicle, and it isn’t a ...

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is currently ...

LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...

T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.

A single-center study suggests the surgery is safe and effective even when tumors are large or located in high-risk areas.

Basal cell carcinomas (BCCs ... a product of the fact that these lesions are obvious to the naked eye. Indeed, as we have been able to examine internal tissues more closely, the incidence of ...

Osteochondral lesions (OCLs) of the talus are rare but can be associated ... The ability of mesenchymal stem cells (MSCs) to differentiate along cell lines of mesodermal lineage (including osteoblasts ...

Eight weeks after completion of the therapy, 11 lesions (55%) clinically showed complete remission, six lesions (30%) showed partial remission, and two lesions (10%) showed no response.

The aim of our study was to evaluate the efficacy and long-term results of interferon a-2a (IFNa-2a) in the treatment of basal cell carcinoma. Results: Eleven lesions (55%) showed complete ...